Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)

The urokinase plasminogen activator receptor (uPAR) plays a role in tumor progression and has been proposed as a target for the treatment of cancer. We recently described the development of a novel humanized monoclonal antibody that targets uPAR and has anti-tumor activity in multiple xenograft anim...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiang, Cai, Yuan, Wei, Ying, Donate, Fernando, Juarez, Jose, Parry, Graham, Chen, Liqing, Meehan, Edward J., Ahn, Richard W., Ugolkov, Andrey, Dubrovskyi, Oleksii, O'Halloran, Thomas V., Huang, Mingdong, Mazar, Andrew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897428/
https://www.ncbi.nlm.nih.gov/pubmed/24465541
http://dx.doi.org/10.1371/journal.pone.0085349

Ejemplares similares

Ejemplares similares